Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the iron deficiency anemia market right now?

Over the past few years, the market size for iron deficiency anemia has seen robust growth. It is projected to expand from a value of $3.37 billion in 2024 to $3.58 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.3%. The growth observed during the historic period is due to several factors including efforts from non-government bodies, a surge in chronic disorder cases, enhanced concentration on parental care, campaigns aimed at raising awareness about nutritional deficiency, and the wide spread of telemedicine.

How fast Is the iron deficiency anemia market expected to grow, and what’s its future value?

The market for iron deficiency anemia is poised for considerable expansion in the coming years, with projections forecasting a rise to $4.55 billion by 2029, indicating a compound annual growth rate (CAGR) of 6.2%. This growth trajectory during the forecast period could be linked to an amplified emphasis on women’s health, an escalating demand for minimally invasive treatments, easy access to over-the-counter solutions, widening of distribution networks, and the increased preference for personalized medication regimes. Some of the forecast period’s significant trends comprise innovative approaches to drug delivery, enhancement in diagnostic tools, advanced monitoring devices, the advent of combination therapies, and the incorporation of nanotechnology in the administration of drugs.

Get your iron deficiency anemia market report here!

https://www.thebusinessresearchcompany.com/report/iron-deficiency-anemia-global-market-report

What are the leading drivers of growth in the iron deficiency anemia market?

A surge in nutritional deficiency instances is anticipated to boost the iron deficiency anemia market. Nutritional deficit pertains to a situation where a person’s body is missing sufficient amounts of vital nutrients such as proteins, vitamins, fats, or minerals needed for optimum health. The unhealthy choice of diet, including the excessive consumption of processed foods along with food scarcity, has escalated the instances of nutritional deficiencies, particularly in impoverished communities struggling with access to nutrient-rich food options. One common type of nutritional deficit is iron deficiency anemia, resulting from an iron-poor diet that results in reduced red blood cell counts, subsequently compromising the body’s capacity to transport oxygen. For example, the National Health Services, a government department based in the UK, reported that the total number of hospital admissions for nutritional deficiency in the UK reached 250,000 in the 2021/22 but then doubled the subsequent year to 500,000 in 2022/23. Therefore, the increasing instances of nutritional deficiencies are driving the expansion of the iron deficiency anemia market.

What are the key segments defining the iron deficiency anemia market?

The iron deficiency anemia market covered in this report is segmented –

1) By Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion

2) By Distribution Channel: Hospital Pharmacy, Drug Stores and Retail Pharmacies, Online Pharmacies

3) By End Users: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Oral Iron Therapy: Ferrous Sulfate, Ferrous Gluconate, Ferrous Fumarate, Polysaccharide-Iron Complex, Carbonyl Iron

2) By Parenteral Iron Therapy: Iron Sucrose, Ferric Carboxymaltose, Iron Dextran, Ferumoxytol, Ferric Gluconate

3) By Red Blood Cell Transfusion: Leukocyte-Reduced Red Blood Cell Transfusion, Washed Red Blood Cell Transfusion, Irradiated Red Blood Cell Transfusion

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21212&type=smp

Who are the key players steering the development of the iron deficiency anemia market?

Major companies operating in the iron deficiency anemia market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Fresenius SE & Co. KGaA, Sandoz International GmbH, CSL Limited, Daiichi Sankyo Company Limited, Perrigo Company, Cipla Limited, Dr. Reddy’s Laboratories Limited, Cadila Healthcare Limited, Zydus Cadila, Lupin Limited, Alkem Laboratories Limited, AMAG Pharmaceuticals Inc., Akebia Therapeutics Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, AdvaCare Pharma LLC

What key trends are currently impacting the iron deficiency anemia market’s development?

Leading firms in the iron deficiency anemia market are striving to innovate, with a key focus on solutions like intravenous iron injection. These methods offer a tailored nutrient mix, heightening absorption and boosting tolerance, thus efficiently combatting iron deficiency. The medical procedure of intravenous iron injection directly administers iron into the bloodstream, effectively treating iron deficiency or anemia when oral supplements prove insufficient or ineffective. For example, Cadila Pharmaceuticals, a pharmaceutical enterprise based in India, introduced Redshot FCM, an intravenous iron injection imbued with ferric carboxymaltose, in March 2024. This groundbreaking product, designed to treat iron deficiency anemia efficiently, is recommended for adults and children aged one year and over who are unable to tolerate oral iron supplements. The product’s solid safety record along with a minimal anaphylaxis risk allows for high-dose iron administration within a single sitting, thus enabling swift enhancements in hemoglobin levels. This solution proves particularly helpful for susceptible demographics like expectant women, cancer patients, and the elderly.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21212

Which regions are most influential in expanding the iron deficiency anemia market?

North America was the largest region in the iron deficiency anemia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Albumin Excipient Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/albumin-excipient-global-market-report

Albumin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Small Cell Lung Cancer Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: